ENTITY
Innovent Biologics Inc

Innovent Biologics Inc (1801 HK)

516
Analysis
Health CareChina
Innovent Biologics, Inc. operates as a biopharmaceutical company. The Company develops, manufactures, and distributes monoclonal antibody drug candidates for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and other diseases. Innovent Biologics serves customers in China.
more
04 Nov 2025 05:30

HSCEI Index Rebalance Preview: 3 Changes as Adds Go Up, Up & Away

There could be 3 changes for the HSCEI in Dec. Estimated turnover is 4% and round-trip trade is HK$5.15bn. Shorts have been covering in the...

Logo
1k Views
Share
03 Nov 2025 11:30

Hong Kong Connect Flows (October): $792m Outflows from Healthcare

We estimated the inflows to Hong Kong stocks from mainland investors to be USD 11bn in October and noted outflows of $792m from Healthcare sector.

Logo
437 Views
Share
02 Nov 2025 10:05

HK Connect Flows Weekly (Oct 31st): CNOOC, SMIC, Alibaba, China Mobile, CSPC Pharma, Tencent

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for CNOOC, SMIC, Alibaba, China Mobile, CSPC Pharma, Tencent,...

Logo
280 Views
Share
27 Oct 2025 09:56

HK Connect SOUTHBOUND Flows (2wks To 24 Oct 2025); Big Flows on Downdraft, Lower Flows on Rebound

SOUTHBOUND volumes remain high. Higher in the downdraft than this past week's rebound, but still generically high. Net flows remain consistent even...

Logo
512 Views
Share
26 Oct 2025 10:05

HK Connect Flows Weekly (Oct 24th): Alibaba, CNOOC, Pop Mart Intl, Duality Biotherapeutics

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Alibaba, CNOOC, Pop Mart Intl, Duality Biotherapeutics,...

Logo
296 Views
Share
x